National Congress of Indonesian Endocrinology Association

Plenary Lecture 1: Metformin with 89 effects: Metabolic-, cardio-, reno-, and cancer-protection (from old medication to new fashion)

Prof dr Marzuki Suryaatmadja SpPK+

Metformin with 89 effects: Metabolic-, cardio-, reno-, and cancer-protection (from old medication to new fashion)


Symposium 1: Recent advances of insulin therapy in diabetes management

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Modification of molecular insulin structure and clinical outcome improvement

benny zulkarnaen+

How to overcome patient and doctor barrier in using insulin treatment: The GAPPtm Result

Symposium 1_ Supportive Screening in Endocrine Abnormality.mp4_snapshot_00.13_[2015.06.11_17.06.04]+

-slide not available-

imam+

Discussion Symposium 1: Recent advances of insulin therapy in diabetes management


Symposium 2: Sexual disorder in children, adult and elderly

fatimah+

-slide not available-

benny santosa+

Adult male hypogonadism

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Disfunction erection on diabetes

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Discussion Symposium 2: Sexual disorder in children adult and elderly


Symposium 3: Diabetes and dyslipidemia

+

-slide not available-

MOV0A7.MOD_snapshot_00.02_[2015.06.12_15.38.43]+

T2DM management in patients with multiple co-morbidities: On top of glycemic control what can saxagliptin do

Sarwono+

Outcome studies on long-term cardiovascular event focus on diabetes and dyslipidemia

Sarwono+

Discussion Symposium 3: Diabetes and dyslipidemia


Symposium 4: Are all DPP4 inhibitor the same?

Prof dr Marzuki Suryaatmadja SpPK+

Personalized approach to improve glycemic control in T2DM management: Current knowledge and future direction

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Renal Impairment: Is this a barrier in achieving A1C target in T2DM

benny zulkarnaen+

Efficacy vs effectiveness in T2DM management: Focus on DPP4-inhibitor

benny zulkarnaen+

Discussion Symposium 4: Are all DPP4 inhibitor the same?


Symposium 5: T2DM management: From guidelines to implementation

Symposium 1_ Supportive Screening in Endocrine Abnormality.mp4_snapshot_00.13_[2015.06.11_17.06.04]+

Type 2 diabetes mellitus requires progressive therapy

imam+

Position of basal insulin in the international guideline: Rational and clinical implementation

fatimah+

-slide not available-

benny santosa+

Discussion Symposium 5: T2DM management: From guidelines to implementation


Symposium 6: Practicing insulin therapy in T2DM

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Various complication of premix insulin: Its development and usage

+

-slide not available-

MOV0A7.MOD_snapshot_00.02_[2015.06.12_15.38.43]+

Latest evidence on insulin treatment – insulin intensification using insulin premix

Sarwono+

Discussion Symposium 6: Practicing insulin therapy in T2DM


Symposium 7: Evaluation of different dyslipidemia guidelines

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

Hidden faces of diabetes: Unmasking diabetic dyslipidemia and newest guidelines on DM

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

Statin therapy in patients with diabetes & CKD: Friend or foe?

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

Cardiometabolic risk, diabetes and CVD: Deep dive on 2015 ADA guideline

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

Discussion Symposium 7: Evaluation of different dyslipidemia guidelines


Symposium 8: Management dyslipidemia based on AACE consensus

Prof dr Marzuki Suryaatmadja SpPK+

-slide not available-

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Effect of statin on renal vascular fuction in diabetes mellitus

benny zulkarnaen+

-slide not available-


Symposium 9: Preparing healthy next generation

Symposium 1_ Supportive Screening in Endocrine Abnormality.mp4_snapshot_00.13_[2015.06.11_17.06.04]+

Gestational weight gain: Nutritional perspectives on energy homeostasis

imam+

-slide not available-

fatimah+

-slide not available-

benny santosa+

Discussion Symposium 9: Preparing healthy next generation


Plenary Lecture 2: Cardiovascular event in diabetes: Pathogenesis and risk analysis

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

-slide not available-


Symposium 10: Progress and promises of DPP4-inhibitor in T2DM management

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

-slide not available-

+

-slide not available-

MOV0A7.MOD_snapshot_00.02_[2015.06.12_15.38.43]+

The benefit early combination therapy: Pathophysiology and its implication

MOV0A7.MOD_snapshot_00.02_[2015.06.12_15.38.43]+

Discussion Symposium 10: Progress and promises of DPP4-inhibitor in T2DM management


Symposium 11: New horizon in type 2 diabetes management through kidney-mediated glucose homeostatis: From research practise

Sarwono+

How can current management of type 2 DM be improved and what does the future hold?

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

-slide not available-

Symposium 3 Management of Hypothyroid Patients.mp4_snapshot_13.33_[2015.06.11_21.15.28]+

Discussion Symposium 11: New horizon in type 2 diabetes management through kidney – mediated glucose homeostatis : from research to practise


Symposium 12: Individualized treatment for type 2 diabetes patients care centered-latest clinical evidence

Prof dr Marzuki Suryaatmadja SpPK+

Chronic care model in diabetes management focus on patient care centre

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Benefit and advances in incretin based therapy in T2DM

benny zulkarnaen+

Cardiovascular outcomes trials among DPP4-inhibotor

benny zulkarnaen+

Discussion Symposium 12: Individualized treatment for type 2 diabetes patients care centered-latest clinical evidence


Symposium 13: Insulin resistance management from pre-diabetes to diabetes

Symposium 1_ Supportive Screening in Endocrine Abnormality.mp4_snapshot_00.13_[2015.06.11_17.06.04]+

Insulin resistance syndrome

imam+

The development of herbal medicine from jamu to phytopharmaceutical

fatimah+

Clinical experiences with DLBS3233 in surabaya prospective study

fatimah+

Discussion Symposium 13: Insulin resistance management from pre-diabetes to diabetes


Symposium 14: Metformin in diabetes: What has evidences told us?

fatimah+

-slide not available-

fatimah+

-slide not available-


Symposium 15: New insight of cardiovascular safety data

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Treating type 2 diabetes while getting cardiovascular benefit

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Oral anti diabetic agent and recent cardiovascular safety data

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Finding the right combination therapy of two anti diabetic drugs

Symposium 2  Management of Hyperthyroid patients.mp4_snapshot_07.23_[2015.06.11_18.37.38]+

Discussion Symposium 15 : New insight of cardiovascular safety data


Symposium 16: Patients safety and medicolegal in JKN era

+

Kendali mutu dan biaya pelayanan kesehatan spesialistik di rumah sakit era jaminan kesehatan nasional

+

Discussion Symposium 16 : Seputar era jaminan kesehatan nasional


CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending